131 More Drugs Have Been Added to the Social Security Institution's Reimbursement List.
10 Articles
10 Articles
The Social Security Institution (SGK) has added 131 more drugs to its reimbursement list, 119 of which are domestically produced. The new list, announced by Minister Vedat Işıkhan, includes 6 cancer drugs, 22 diabetes drugs, 14 pulmonary hypertension drugs, 4 blood products, and 2 allergy vaccines. The number of drugs covered by reimbursement since the beginning of the year has risen to 380.
Minister of Labor and Social Security Vedat Işıkhan made a new statement via a post on his personal X account. 131 more drugs, 119 of which are domestically produced, have been added to the reimbursement list...
Minister of Labor and Social Security Vedat Işıkhan announced that 131 more drugs, 119 of which are domestically produced, have been added to the Social Security Institution's reimbursement list. The new drugs include products used in the treatment of cancer, diabetes, and pulmonary hypertension.
Minister of Labor and Social Security Vedat Işıkhan announced that 131 new drugs, 119 of which are domestically produced, have been added to the Social Security Institution's (SGK) reimbursement list. This brings the total number of drugs covered by reimbursement since the beginning of the year to 380.
Minister of Labor and Social Security Vedat Işıkhan announced that 131 more drugs, 119 of which are domestically produced, have been added to the Social Security Institution's (SGK) reimbursement list. The newly added drugs include 6 cancer medications, 22 diabetes medications, and 14 pulmonary hypertension medications. This brings the total number of drugs covered by reimbursement since the beginning of the year to 380.
Minister of Labor and Social Security Vedat Işıkhan announced that 131 more drugs, 119 of which are domestically produced, have been added to the reimbursement list through the Social Security Institution (SGK). Işıkhan stated that a total of 380 drugs, including 34 cancer drugs, have been added to the list since the beginning of this year.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium











